Jonathan A Galli1, Jason S Krahnke2, A James Mamary2, Kartik Shenoy2, Huaqing Zhao2, Gerard J Criner2. 1. Temple University, Division of Pulmonary and Critical Care Medicine, Philadelphia, PA, USA. Electronic address: Jonathan.galli2@tuhs.temple.edu. 2. Temple University, Division of Pulmonary and Critical Care Medicine, Philadelphia, PA, USA.
Abstract
RATIONALE: Patients with COPD and hypercapnic respiratory failure have a worse prognosis and experience a faster deterioration in their pulmonary function. The benefit of home NPPV following an acute exacerbation of COPD with hypercapnic respiratory failure is not well understood. OBJECTIVES: To evaluate the effect of home NPPV use in patients following a hospitalization for AECOPD with acute hypercapnic respiratory failure on event-free survival after an index admission. METHODS: We conducted a retrospective, single-center, chart review on patients hospitalized in 2011 with a diagnosis of AECOPD, hypercapnia, and used NPPV during hospitalization. 166 patients were included and were divided into two groups: patients who used NPPV post discharge and patients who did not. RESULTS: Patients in the NPPV post discharge group demonstrated superior event-free survival compared to the no-NPPV post discharge group (y2 = 23.8, p < 0.0001). The NPPV post discharge group had a statistically significant reduction in hospital readmissions (40% versus 75%, p < 0.0001) through 180 days from the index admission. CONCLUSIONS: Patients who used NPPV following an admission for AECOPD with hypercapnic respiratory failure had lower readmission rates and improved event-free survival after 180 days from an index admission compared to patients who did not use NPPV post discharge.
RATIONALE: Patients with COPD and hypercapnic respiratory failure have a worse prognosis and experience a faster deterioration in their pulmonary function. The benefit of home NPPV following an acute exacerbation of COPD with hypercapnic respiratory failure is not well understood. OBJECTIVES: To evaluate the effect of home NPPV use in patients following a hospitalization for AECOPD with acute hypercapnic respiratory failure on event-free survival after an index admission. METHODS: We conducted a retrospective, single-center, chart review on patients hospitalized in 2011 with a diagnosis of AECOPD, hypercapnia, and used NPPV during hospitalization. 166 patients were included and were divided into two groups: patients who used NPPV post discharge and patients who did not. RESULTS:Patients in the NPPV post discharge group demonstrated superior event-free survival compared to the no-NPPV post discharge group (y2 = 23.8, p < 0.0001). The NPPV post discharge group had a statistically significant reduction in hospital readmissions (40% versus 75%, p < 0.0001) through 180 days from the index admission. CONCLUSIONS:Patients who used NPPV following an admission for AECOPD with hypercapnic respiratory failure had lower readmission rates and improved event-free survival after 180 days from an index admission compared to patients who did not use NPPV post discharge.
Authors: Nancy H Stewart; Ryan W Walters; Babak Mokhlesi; Diane S Lauderdale; Vineet M Arora Journal: J Clin Sleep Med Date: 2020-10-15 Impact factor: 4.062
Authors: Kristian Brat; Marek Plutinsky; Karel Hejduk; Michal Svoboda; Patrice Popelkova; Jaromir Zatloukal; Eva Volakova; Miroslava Fecaninova; Lucie Heribanova; Vladimir Koblizek Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-03-26
Authors: Cinthya Pena Orbea; Hussam Jenad; Lena Lea Kassab; Erik K St Louis; Eric J Olson; Gaja F Shaughnessy; Lillian T Peng; Timothy I Morgenthaler Journal: J Clin Sleep Med Date: 2021-12-01 Impact factor: 4.062